pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    TNG-260
    Cervical Cancer$TNGX Tango Therapeutics, Inc.
  • Phase 2
    TNG-456
    Bladder Cancer$TNGX Tango Therapeutics, Inc.
  • Preclinical
    TNX-1700
    Colorectal Cancer$TNXP Tonix Pharmaceuticals Holding Corp.
  • Phase 1
← prev
page 36 of 62
next →
Pain89
Neurology1
TORL-2307 MAB
Gastric Cancer
TORL Biotherapeutics LLC
  • Phase 1
    TP-317
    Crohn's Disease (Regional Enteritis) Thetis Pharmaceuticals LLC
  • Phase 1
    TPIV-110
    Ductal Carcinoma In Situ$MRKR Marker Therapeutics, Inc.
  • Phase 1
    TPST-1495
    Adenocarcinoma Of The Gastroesophageal Junction$TPST Tempest Therapeutics, Inc.
  • Preclinical
    TPST-3003
    Refractory Multiple Myeloma$TPST Tempest Therapeutics, Inc.
  • Phase 1
    TRE-515
    Ovarian Cancer Trethera Corp
  • pre_registration
    TRGFT-201
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Orca Biosystems Inc
  • Phase 2
    TRI-611
    Non-Small Cell Lung Cancer TRIANA Biomedicines Inc
  • Phase 2
    TRK-950
    Adenocarcinoma Of The Gastroesophageal Junction Toray Industries Inc
  • Phase 1
    TRX-920
    Unspecified Cancer TaiRx Inc
  • Phase 2
    TSC-100
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$TCRX TScan Therapeutics, Inc.
  • Phase 2
    TSC-101
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$TCRX TScan Therapeutics, Inc.
  • Phase 1
    TSC-203 HLA-A*02:01
    Head And Neck Cancer$TCRX TScan Therapeutics, Inc.
  • Phase 1
    TSN-084
    Triple-Negative Breast Cancer (TNBC) Tyligand Biotechnology (Shanghai) Co Ltd
  • Phase 2
    TSN-1611
    Solid Tumor Tyligand Biotechnology (Shanghai) Co Ltd
  • Phase 2
    TST-003
    Metastatic Colorectal Cancer Transcenta Holding Ltd
  • Phase 1
    TT-01488
    Diffuse Large B-Cell Lymphoma TransThera Sciences (Nanjing) Inc
  • Phase 1
    TT-125
    Non-Small Cell Lung Cancer TOLREMO Therapeutics AG
  • Phase 1
    TTC-352
    Metastatic Breast Cancer TTC Oncology LLC
  • Phase 2
    TTI-101
    Metastatic Hepatocellular Carcinoma (HCC)$TVRD Tvardi Therapeutics, Inc.
  • Phase 1
    TTX-080
    Acral Lentiginous Melanoma Tizona Therapeutics Inc
  • Preclinical
    TTX-siPD-L1
    Pancreatic Ductal Adenocarcinoma$RNAZ Transcode Therapeutics, Inc.
  • Phase 2
    TTXMC-138
    Solid Tumor$RNAZ Transcode Therapeutics, Inc.
  • Phase 2
    TUB-040
    Non-Small Cell Lung Cancer Tubulis GmbH
  • Phase 2
    TVI-Kidney-1
    Renal Cell Carcinoma TVAX Biomedical Inc
  • Preclinical
    TY-0609
    Breast Cancer TYK Medicines Inc
  • Preclinical
    TYG-100
    Gastrointestinal Tract Cancer Tyg Oncology Ltd